The serine/threonine kinase 5 0 adenosine monophosphateactivated protein kinase (AMPK), a heterotrimeric protein known as a metabolic switch, is involved in oocyte nuclear maturation in mice, cattle, and swine. The present study analyzed AMPK activation in cumulus cell expansion during in vitro maturation (IVM) of porcine cumulus-oocyte complexes (COC). 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) is a well-known activator of AMPK. It inhibited oocyte meiotic resumption in COC. Moreover, cumulus cell expansion did not occur in the presence of AICAR, demonstrating its marked impact on cumulus cells. Activation of AMPK was supported by AICAR-mediated phosphorylation of alpha AMPK subunits. Furthermore, the presence of AICAR increased glucose uptake, a classical response to activation of this metabolic switch in response to depleted cellular energy levels. Neither nuclear maturation nor cumulus expansion was reversed by glucosamine, an alternative substrate in hyaluronic acid synthesis, through the hexosamine biosynthetic pathway, which ruled out possible depletion of substrates. Both increased gap junction communication and phosphodiesterase activity in COC are dependent on protein synthesis during the initial hours of IVM; however, both were inhibited in the presence of AICAR, which supports the finding that activation of AMPK by AICAR mediated inhibition of protein synthesis. Moreover, this protein synthesis inhibition was equivalent to that of the well-known protein synthesis inhibitor cycloheximide, as observed on cumulus expansion and protein concentration. Finally, the phosphorylation level of selected kinases was investigated. The pattern of raptor phosphorylation is supportive of activation of AMPK-mediated inhibition of protein synthesis. In conclusion, AICAR-mediated AMPK activation in porcine COC inhibited cumulus cell expansion and protein synthesis. These results bring new considerations to the importance of this kinase in ovarian physiology and to the development of new oocyte culture medium.
INTRODUCTION
Meiosis in mammalian oocytes begins during fetal life and is interrupted at the dictyate stage, before the end of the first prophase. The most salient feature of this meiotic arrest is the formation of a large germinal vesicle (GV) containing the oocyte nucleus. The oocyte remains at the GV stage until a few hours before ovulation. However, the oocyte is far from ready for ovulation at this stage and must grow in order to acquire meiotic competence. This requires activation of the molecular machinery that permits resumption of meiosis and occurs at approximately the same time as the ovarian follicle forms an antrum. Meiosis will resume spontaneously if a cumulusoocyte complex (COC) is isolated and cultured in vitro at this point [1, 2] . In swine, spontaneous meiotic resumption is substantially slower than in other animals such as mouse, rat, and bovine.
Numerous molecular control mechanisms have been reported to regulate the meiotic cell cycle in oocytes. One of these mechanisms involves cyclic adenosine monophosphate (cAMP), which is synthesized by adenylyl cyclase and primarily activates cAMP-dependent protein kinase (PKA). The enzyme adenosine-monophosphate-activated protein kinase (AMPK) is also involved in oocyte meiosis [3] and is a serine/threonine kinase member of the AMPK/SNF1 protein kinase family. It is a heterotrimer with 2 isoforms of the a and b subunits and 3 isoforms of the c subunit [4] . Activators of AMPK cause meiosis to resume in murine oocytes under otherwise inhibitory conditions [3] ; however, AMPK activators inhibit the resumption of meiosis in porcine and bovine oocytes cultured in vitro [5, 6] . A recent study comparing rat and mouse oocytes showed a clear difference in the regulation of meiosis, emphasizing the differences in response to AMPK activators [7] .
The female gamete is surrounded by somatic cells and forms an electrophysiological syncytium with cumulus cells and granulosa cells. Gap junction communication allows the flow of signaling molecules and glucose metabolites. In swine, these junctions are highly regulated during in vitro maturation (IVM) [8, 9] . Three different research groups have proposed that the cyclic nucleotide cGMP might be the inhibitory signal transferred from cumulus cells to the oocyte through gap junctions [10] [11] [12] . One of the proposed targets of cGMP is cGMP-inhibited phosphodiesterase (PDE3), which is functionally present in mammalian oocytes [13, 14] . In preovulatory follicles following the ovulatory surge of luteinizing hormone, cumulus cells initiate the induction of unique genes, leading to secretion of extracellular matrix materials such as hyaluronic acid (HA), the HA-binding protein pentraxin-3, and the tumor necrosis factor-alpha-induced protein 6 (TNFAIP6), protease ADAM metallopeptidase with thrombospondin type 1 motif (ADAMTS1), and the aggregating proteoglycan versican [15] . Hyaluronic acid is synthesized from glucose via the hexosamine biosynthetic pathway [16] , forms the backbone of the extracellular matrix, and is required for cumulus expansion. Synthesis of this protein is induced by follicle-stimulating hormone (FSH), epidermal growth factor (EGF), and other soluble factors [17] [18] [19] [20] .
In view of the inhibitory effect of AMPK activators on the resumption of meiosis [6] , this study was undertaken to analyze the response to AMPK activators in cumulus cell expansion during IVM of porcine COC.
MATERIALS AND METHODS

Chemicals
Millimolar stocks of 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside (AICAR) and 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranosyl 5 0 -monophosphate (ZMP) were dissolved in the maturation medium and stored at À208C. AICAR was purchased from Toronto Research Chemicals Inc. Unless otherwise stated, metformin, 5 0 adenosine monophosphate (5 0 AMP), EGF, cycloheximide, and all other chemicals used in this study were purchased from Sigma Chemical Co. The chemicals were added to the maturation medium approximately 3 h before the initiation of oocyte culture. The final concentrations of dimethyl sulfoxide (DMSO) in culture medium never exceeded 0.1%. The control treatment consisted of oocytes incubated in medium without inhibitors or DMSO.
Collection of Ovaries
Ovaries were collected from prepubertal gilts at a local slaughterhouse and transported in a thermos containing saline solution (0.9% NaCl) supplemented with 100,000 IU/L penicillin G, 100 mg/L streptomycin, and 250 mg/L amphotericin B. Ovaries were maintained at 348C and rinsed with saline upon arrival.
IVM Medium
Oocytes were matured in bovine serum albumin (BSA)-free North Carolina State University 23 medium [21] supplemented with 25 lM b-mercaptoethanol (Bio-Rad, Hercules, CA), 0.1 mg/ml cysteine, 10% (v/v) porcine follicular fluid (pFF), and gonadotropins (final concentrations of 2.5 IU/well for hCG [APL; Ayerst Laboratories Inc.] and 2.5 IU/well for eCG [Folligon; Intervet]) as previously described [22, 23] . Porcine follicular fluid was collected from follicles (2-6 mm in diameter) of prepubertal gilt ovaries, using an 18-guage needle and a 10-ml syringe. After centrifugation at 1500 3 g for 30 min at room temperature, the supernatant was filtered through 0.8-lm and 0.45-lm syringe filters and stored at À208C until used [23] .
Collection of Cumulus-Oocyte Complexes
Porcine COC were collected as described previously [23] . Follicles measuring 2-6 mm in diameter were aspirated with a 10-ml syringe and an 18-guage needle. The follicular contents were pooled in 50-ml conical tubes (Falcon). After sedimentation, the pellet was washed twice in pFF. Cumulusoocyte complexes were recovered by using a stereomicroscope and transferred to a Petri dish containing follicular fluid supernatant. The COC were washed three times with HEPES-buffered Tyrode medium containing 0.01% (w/v) polyvinyl alcohol (PVA-TLH) [24] and then subjected to their respective treatments. Groups of 25-30 COC were placed in the wells of 4-well multidishes (Nunc) containing 500 ll of maturation medium. The COC were cultured at 38.58C in an atmosphere of 5% CO 2 in air at 100% relative humidity. The culture medium was supplemented with gonadotropins once the oocytes were in culture.
Selection of COC and Preparation of Denuded Oocytes
Cumulus-oocyte complexes with at least three layers of clear and compact cumulus cells surrounding the oocyte were selected as previously described [23] . Complexes with dark, pyknotic or expanded cumulus cells at the time of selection or those containing oocytes with a very clear cytoplasm or small diameter were discarded. Cumulus cells were then removed by repeatedly drawing the complex into a pipette in a 2-ml centrifuge tube containing 60 ll of PVA-TLH. Denuded oocytes were rinsed twice in maturation medium, recovered using a stereomicroscope, and those with a homogeneous cytoplasm were then distributed among the treatments.
Evaluation of Nuclear Maturation
The oocyte nuclear maturation stage was evaluated as described previously [23] , using phase contrast microscopy at magnifications of 3100 and 3400 immediately after staining with 1% aceto-orcein [25] following a 24-h fixation period in a solution of ethanol and acetic acid (3:1). Oocytes containing a nuclear membrane were considered at the GV stage, whereas those without a nuclear membrane were considered to have resumed meiosis.
Uptake of Glucose Analog 6-NBDG
Groups of 30 porcine COC underwent standard IVM for 2, 4, or 20 h in the presence or absence of AICAR. Two hours before the end of treatment, COC were treated with 100 lM 6-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl] amino)-6-deoxyglucose (6-NBDG; Invitrogen). At the end of the treatment, COC were rinsed twice with PVA-TLH and then fixed with 4% paraformaldehyde for 5 min at room temperature. Cumulus-oocyte complexes were labeled with propidium iodide and then mounted on glass slides. Epifluorescence microscopy was carried out using an Eclipse E600 microscope (Nikon). Standard light microscopy and epifluorescence photos for propidium iodide and 6-NBDG were taken of individual COC by using the Simple PCI program version 5.2.0.2404 (Compix Inc.). The intensity of the signal was evaluated using Image J version 1.37 software (U.S. National Institutes of Health). ; product number C-3100; Molecular Probes) in IVM medium containing 0.1 mg/ml PVA as described previously [26] . After holding for 20 min at 38.58C, the live COC were mounted on glass slides in the PVA-containing IVM medium. Fluorescence recovery after photobleaching (FRAP) assays were conducted with an Eclipse TE2000-E inverted confocal microscope (Nikon). Calcein bleaching was performed for 5 min by using laser pulses on a limited region of cumulus cells observed at a magnification of 390. COC were photographed at magnification 360 before laser use and every 3 min thereafter for up to 12 min. Fluorescence intensity was quantified using Image J version 1.37 (NIH). A relative fluorescence value was achieved by dividing the raw fluorescence measurement in the bleached area by the mean fluorescence in two adjacent regions. This value was further divided by the fluorescence value of a region at the opposite end of the COC to correct for unintended bleaching caused by the laser excitation.
Cumulus-Cumulus Gap-FRAP Assay
Immunoblotting
Groups of 10 porcine COC were run on 10% SDS-polyacrylamide gels. The proteins were transferred to Hybond-P membranes (GE Healthcare) using the Mini-Protean 3-cell apparatus (Bio-Rad). Membranes were blocked for 1 h with Tris-buffered saline (TBS) containing 0.05% (v/v) Tween 20 and 5% skimmed milk. Hybridization was performed overnight at 48C in TBS-Tween containing the primary antibody. Table 1 lists the primary antibodies and dilutions used for hybridization. The membranes were then washed three times in TBS-Tween and hybridized for 1 h at room temperature with the secondary antibody, namely peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG; Upstate Biotechnology) diluted 1:20 000 in the blocking buffer or peroxidase-conjugated goat anti-rabbit IgG (Jackson Laboratories) diluted 1:30 000. Detection was performed using an enhanced chemiluminescence kit, and the membranes were photographed with a model FX7 digital camera (Fusion), and images were analyzed using Fusion FX software.
Phosphodiesterase Assay
Tissues were suspended in hypotonic buffer (20 mM Tris-HCl [pH 7.4], 1 mM EDTA, 0.2 mM EGTA, 50 mM NaF, 50 mM benzamidine, 10 mM sodium SANTIQUET ET AL. pyrophosphate, 4 lg/ml aprotinin, 0.7 lg/ml pepstatin, 10 lg/ml soybean trypsin inhibitor, 0.5 lg/ml leupeptin, and 2 mM phenylmethylsulfonyl fluoride) and homogenized by nine freeze-thaw cycles accompanied by vortex agitation. In all experiments, the hypotonic buffer contained 0.5% Triton X-100 as detergent. Tris-HCl was purchased from Fisher Scientific Ltd. The homogenate was centrifuged for 20 min at 13 000 3 g to obtain the supernatant. Phosphodiesterase (PDE) activity was assayed at 348C in a final volume of 200 ll with 1 lM cAMP as substrate, following the method of Thompson et al. [27] with minor modifications [28] . The solution consisted of 40 mM Tris-HCl (pH 8.0), 10 mM MgCl 2 , 5 mM 2-mercaptoethanol, 0.75 mg/ml BSA (fraction V), 1 lM non-radiolabeled cAMP, and 15 nM [
3 H]cAMP (1 3 10 5 cpm/tube; 30 Ci/ mmol; GE Healthcare). Measurements were performed in the presence of the PDE inhibitor cilostamide (10 lM, PDE3-specific). Cilostamide-sensitive (PDE3) PDE activities were obtained by subtracting the PDE activity measured in the presence of cilostamide from the total activity. Cilostamide was purchased from BioMol (Plymouth Meeting, PA).
Protein Quantification
After treatment, the COC were washed twice in PVA-TLH, followed by flash freezing in minimal volume and were stored at À808C until used. Protein content was determined after homogenization of COC following the method described above. The protein content was measured in the supernatant (13 000 rpm, 48C, 20 min) using the Pierce BCA protein assay kit (Thermo Science).
Statistical Analyses
The percentage of oocytes at the GV stage was expressed as the mean 6 SEM of a minimum of three replicates. Data were analyzed using one-way ANOVA, using GraphPad Prism version 5.0 (GraphPad Software) for Windows (Microsoft). When ANOVA indicated a significant treatment effect (P , 0.05), individual treatment differences were compared using a Bonferroni multiple comparison post hoc test. Data for glucose uptake were analyzed by the nonparametric Mann-Whitney test to assess the significant effect of treatment, using Prism software (GraphPad).
RESULTS
AICAR Inhibits Oocyte Meiotic Resumption During IVM
Porcine oocytes are in meiotic arrest prior to IVM (Fig.  1A) . After 24 h of IVM, most of the oocytes resumed meiosis, and only a small percentage (10.6% 6 4.1%) remained at the GV stage (i.e., remained in meiotic arrest). In contrast, 88.6% 6 2.8% of COC cultured in the presence of AICAR were arrested at the GV stage, as reported previously [6] . However, the percentage of denuded oocytes remaining at the GV stage in the presence of AICAR was significantly lower (Fig. 1A) . These data support the fact that AICAR mediates its inhibitory effect on porcine oocyte meiotic resumption through cumulus cells. This corroborates previous work using the alternative AMPK activator ZMP [6] and lends support to the present study aim of assessing the effect of AICAR on cumulus cells.
Effect of AICAR on Porcine Cumulus Cell Expansion
Cumulus expansion occurred during IVM, leading to substantial enlargement of the COC at the end of the 24-h culture period (Fig. 1B2 ) compared to the initial status (Fig.  1B1 ). In the presence of AICAR, the cumulus expansion observed after 24 h was negligible (Fig. 1B3) . The effects of AICAR on both oocyte nuclear maturation and cumulus expansion were examined further using increasing concentrations of AICAR. The effects of AICAR on both oocyte nuclear maturation and cumulus expansion were dose-dependent (Fig.  1C) . In addition, the inhibitory effects of different AMPK activators on nuclear maturation and cumulus expansion after a 24-h treatment period are illustrated in Figure 1D . The effects of AICAR, ZMP, metformin, and 5 0 AMP showed an inhibition of oocyte nuclear maturation, but only AICAR promoted full inhibition of cumulus cell expansion compared to the other pharmacological compounds (Fig. 1D) .
Does EGF, a Factor Promoting Cumulus Expansion, Reverse AICAR Treatment?
It is well established that EGF promotes oocyte maturation [29] , as observed by oocyte nuclear maturation [30] and also by cumulus cell expansion [31] . These effects of EGF have also been described in porcine COC [32] [33] [34] [35] . The aim of the next experiment was to investigate whether EGF was able to stimulate oocyte nuclear maturation and cumulus cell expansion in AICAR-treated COC. Epidermal growth factor alone was effective in stimulating cumulus cell expansion (data not shown), and a clear stimulation of cumulus expansion was also observed in the combination of EGF and eCG/hCG-treated COC (Fig. 1F3) . Epidermal growth factor did not reverse the inhibitory effect of AICAR on either oocyte nuclear maturation (Fig. 1E ) or cumulus cell expansion (Fig. 1F4 ). Under these conditions, EGF was not able to reverse the inhibition of oocyte nuclear maturation and cumulus cell expansion.
AMPK Activation Using AICAR
The objective of this experiment was to demonstrate that AMPK was activated by AICAR in porcine COC. Activation of AMPK was measured by phosphorylation of the AMPK alpha subunits (alpha 1 and 2) by using Western blotting ( Fig.  2A) . In the control culture, there was no significant change in phosphorylation status of the AMPK alpha subunits between 0 h and 20 h in the COC during IVM (Fig. 2B) . However, a significant increase in alpha-phospho-AMPK was measured by densitometric analysis after incubation in the presence of AICAR for 20 h (Fig. 2B) , demonstrating AMPK activation by AICAR in porcine COC. 
Glucose Uptake
Among the numerous effects resulting from AMPK activation is an increase in glucose uptake by the cells [36] . Furthermore, glucose is a key molecule for HA synthesis [37] , a major component of the extracellular matrix synthesized during cumulus expansion [38] . An increase in glucose uptake following AMPK activation might be expected to increase cumulus expansion; however, AICAR-treatment inhibited cumulus expansion (Fig. 1B3) . The nonmetabolic glucose analog 6-NBDG was used to determine whether AMPK activation decreased glucose uptake by COC. Uptake of 6-NBDG in the presence of AICAR was observed after 2 and 4 h of IVM but became significantly higher than the control condition after 20 h of IVM (Fig. 3A) . These data clearly show that AMPK activation stimulates glucose uptake, thereby excluding the possibility of glucose deficiency during HA biosynthesis via the hexosamine biosynthetic pathway.
Glucose Utilization
Glutamine-fructose-6-phosphate-transaminase-1 (GFPT1) is an important rate-limiting enzyme in the hexosamine biosynthetic pathway [39] that catalyzes the conversion of fructose-6-phosphate to glucosamine 6-phosphate, an essential step in HA synthesis (Fig. 4A) . The metabolic enzyme PFK2 (6-phosphofructo-2-kinase) uses fructose-6-phosphate to enter the glycolysis pathway. PFK2 is known to be phosphorylated by AMPK [40] . Because AMPK activation could then potentially alter glucose metabolism at multiple points along the hexosamine biosynthetic pathway, glucosamine supplementation might compensate for this and thereby promote cumulus cell expansion by serving as an alternative source of glucose that entered the pathway downstream from the critical enzyme GFPT1 [41] . The results showed that glucosamine had no significant effect on oocyte nuclear maturation or cumulus cell expansion, nor did addition of glucosamine to AICAR-treated COC reverse the inhibition of either oocyte nuclear maturation or cumulus cell expansion (Fig. 4) . These data support the fact that in the process of cumulus cell expansion, the substrates were not limiting when cultured in the presence of AICAR. Results suggest that AICAR does not inhibit cumulus cell expansion through the first step of the hexosamine biosynthesis pathway upstream of GFPT1 but alter protein synthesis required for extracellular matrix synthesis.
Cumulus-Cumulus Gap-FRAP Assay
Characterization of cumulus-cumulus gap junction communication using the Gap-FRAP assay was performed using the same method as previously reported [26] . After a 4-h culture period in the presence of AICAR, the fluorescence recovery 3 . Effect of AICAR treatment on uptake of glucose analog 6-NBDG by COC during IVM. Uptake of 6-NBDG by COC. Cumulus-oocyte complexes were cultured for 2, 4, and 20 h in the presence or absence of AICAR (2 mM). Two hours before the end of treatment, COC were exposed to 100 lM 6-NBDG and then rinsed and exposed briefly to propidium iodide. Asterisks indicate significant differences (P , 0.05) according to Mann-Whitney test results.
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were cultured for 24 h with increasing concentrations of AICAR. Each data point represents means 6 SEM of three replicates. Cumulus expansion ratings are 0 0 (none), þ (slight), þþ (moderate), þþþ (large), and þþþþ (full). D) Effects of the AMPK activators AICAR, ZMP, metformin, and 5 0 AMP (all at 2 mM) on nuclear maturation and cumulus cell expansion in cultured COCs. The percentage of oocytes at GV stage was evaluated after incubation for 24 h in the presence of gonadotropins. Data points represent means 6 SEM of at least three replicates. Cumulus expansion ratings are 0 0 (none), þ (slight), þþ (moderate), þþþ (large), and þþþþ (full). E) Effects of EGF on nuclear maturation and cumulus cell expansion in AICAR-treated COC. Cumulus-oocyte complexes were matured for 24 h under control conditions or in the presence of 2 mM AICAR, 300 nM EGF, or AICAR and EGF. Data points represent means 6 SEM of 3 replicates. Statistical analysis was performed by ANOVA (P , 0.05). Different letters indicate significant differences according to Bonferroni paired comparison post hoc test results. The numbers of oocytes according to treatment are indicated in parenthesis. F) Cumulus cell expansion after 24 h IVM, respectively: 1) control; 2) AICAR; 3) EGF; 4) EGF þ AICAR. Original magnification 350 (B and F).
AMPK ACTIVATION INHIBITS CUMULUS EXPANSION
FIG. 4. Effect of glucosamine on nuclear maturation and cumulus cell expansion in AICAR-treated COC.
A) Hexosamine biosynthetic pathway; hyaluronic acid synthesis from glucose and glucosamine. Glutamine-fructose-6-phosphate-transaminase-1 (GFPT1) is a rate-limiting enzyme that can be bypassed by glucosamine. B) COC were incubated under control conditions, with 2 mM glucosamine, with 2 mM of AICAR, or with glucosamine and AICAR for 24 h. Data points represent mean 6 SEM of 3 replicates. Statistical analysis was performed by ANOVA (P , 0.05). Different letters indicate significant differences according to Bonferroni paired comparison post hoc test results. C) Cumulus cell expansion after 24-h IVM. Treatments are presented in the same sequence as described in the legend to B. Original magnification 350. measured in cumulus cells was significantly decreased compared with that in the control condition (Fig. 5A ). Connexin 43 (Cx43) has a major role in the building of functional junctions between cumulus cells [26] . Because translational regulation of Cx43 has been reported in porcine COC [8, 26] and a decrease in communication was measured in presence of AICAR, the effect of AICAR on Cx43 protein levels was assessed (Fig. 5B) . After 4 h of IVM, a significant increase in the Cx43:a-tubulin ratio was observed in the control treatment (Fig. 5C ) in agreement with previously reported observations [8, 26] . However, AICAR treatment significantly inhibited the increase in Cx43, suggesting that activation of AMPK resulted in a decrease in gap junction communication between cumulus cells by inhibiting Cx43 protein synthesis.
Phosphodiesterase Assay
Phosphodiesterase activity was measured in COC at 0 and 20 h of IVM. As previously reported [42] , total PDE activity was more than 3-fold increased after 20 h (Fig. 6 ). This increase was primarily attributed to the increase in cilostamidesensitive activity (i.e., PDE3, the cGMP-inhibited PDE) (Fig.  6) , and supports the translational upregulation of PDE3 in porcine COC [42] . In the presence of AICAR, the increase in PDE activity was significantly reduced compared with that in the control, suggesting that AMPK activation inhibited PDE3 upregulation in response to gonadotropins, which is also dependent on protein synthesis [42] .
Protein Synthesis Is Inhibited by AICAR
To address whether activation of AMPK inhibits protein synthesis, the AICAR response was compared with cycloheximide, a well-known protein synthesis inhibitor. Cumulus cell expansion (Fig. 7A1 ) was inhibited by AICAR (Fig. 7A2) to the same extent as that observed in cycloheximide-treated COC (Fig. 7A3 ) after 20 h of IVM. Protein content was measured using the BCA protein assay kit, and results show the occurrence of protein synthesis in cumulus cells between 0 and 20 h of IVM (Fig. 7B) . This synthesis was significantly inhibited in the presence of AICAR and to a similar extent as that observed for cycloheximide treatment. These observations support that activation of AMPK inhibited protein synthesis.
There are few kinases involved in the control of protein synthesis, which are targets for AMPK. It was recently reported that the mammalian target of rapamycin (mTOR) is targeted by AMPK during protein synthesis inhibition [43] . AICARactivated AMPK directly phosphorylates tuberous sclerosis 2 (TSC2) [44] and regulatory-associated protein of mTOR (raptor) [45] , resulting in the inhibition of TOR complex 1 signaling; therefore, TOR complex 1 activity was monitored by measuring the levels of phosphorylation of mTOR, TCS2, and raptor using a Western blotting approach. Raptor phosphorylation was 2.5-fold increased in AICAR-treated COC compared to that in control (Fig. 7C) . However, the phosphorylation levels for TSC2 and mTOR were not increased that much, 1.2-and 1.1-fold, respectively. Thus, the 2.5-fold increase in raptor phosphorylation in AICAR-activated AMPK provides further support of TOR complex 1 decreased activity leading to the inhibition of protein synthesis in cumulus cells. SANTIQUET ET AL.
DISCUSSION
The present study assessed the response to AICAR, a wellknown AMPK activator, in porcine COC, with particular reference to oocyte nuclear maturation and cumulus cell expansion during IVM. First, AICAR inhibited spontaneous meiotic resumption during IVM but only when cumulus cells surrounded the oocyte. Second, AICAR inhibited cumulus cell expansion, which normally occurs in response to FSH and/or EGF during IVM. The alpha subunits of AMPK were phosphorylated in response to AICAR treatment in porcine COC, supporting the fact that AICAR is activating AMPK in porcine COC; however, the AMPK targets in this system remain unknown. Nonetheless, activation of AMPK has been shown to inhibit protein synthesis in many different cell types [46, 47] . It is known that both gap junction communication and PDE activity are under protein synthesis regulation during IVM and, as such, were considered potentially regulated by AMPK. A broad inhibition of protein synthesis in porcine COC was supported by the observations that AICAR inhibited both the increase in gap junction communication by Cx43 and an increase in PDE activity. Moreover, cumulus cell expansion in response to FSH during IVM was inhibited by AICAR to the same extent as that by treatment with the protein synthesis inhibitor cycloheximide. This result was validated by measuring a marked decrease in protein content after treatment with AICAR. Furthermore, several kinases involved in the control of protein synthesis were studied as potential targets of AICAR activated-AMPK. The increased phosphorylation of raptor is supportive of a decreased TOR complex 1 activity leading to an inhibition of protein synthesis.
We have previously shown that ZMP, an AMPK activator, delays nuclear maturation in swine oocytes but only in the presence of cumulus cells [6] . Here we show that meiotic resumption was also inhibited by AICAR in COC (Fig. 1A) ; however, cumulus cells were essential in promoting this inhibitory effect as reported for ZMP [6] . These results support a major role for these somatic cells in the transmission of the effects of AMPK activators to oocyte nuclear maturation. Indeed, the effect of AICAR is dose-dependent (Fig. 1C) . The differential inhibitory efficacy of the different AMPK activators was also compared, showing that all tested AMPK activators are able to inhibit spontaneous meiotic resumption during IVM in swine (Fig. 1D ). This inhibitory effect on meiosis has also been shown in cattle [5, 48] , whereas the effect in mice is diametrically opposite. In murine COC, AMPK activators induce oocyte maturation, as demonstrated by the reversal of the meiosis-inhibiting effects produced by cAMP analogs, specific PDE3 inhibitors, or hypoxanthine [3] . In invertebrate species such as the nemertean worm, AMPK activators inhibit oocyte nuclear maturation but only in the absence of the surrounding somatic cells [49] . These studies collectively support the hypothesis that the role of AMPK is species-specific, as each species during the course of its evolution may have adapted its own mechanism of managing energy metabolism, resulting in different responses to AMPK activation.
The AMPK activators inhibit not only oocyte nuclear maturation but also cumulus cell expansion to various degrees. Figure 1D shows that cumulus cell expansion was still occurring in the presence of metformin, ZMP, and 5 0 AMP, whereas treatment with AICAR showed no cumulus cell expansion. A recent study of cattle oocytes concluded that cumulus cell expansion was not significantly affected by metformin, a known AMPK activator, after 24 h of IVM [48] .
Since AICAR inhibits the resumption of meiosis and expansion of cumulus cells in the COC when stimulated with gonadotropins ( Figure 1A) , we wanted to investigate the additive effect of EGF to reverse this inhibition. EGF has long been recognized as a powerful stimulator of cumulus cell expansion [29] , and results from our study showed that EGFstimulated cumulus cell expansion was inhibited in the presence of AICAR (Fig. 1F) . More recently, EGF-like peptides such as epiregulin, amphiregulin, and beta-cellulin have been described as having a role in the induction of cumulus cell expansion and oocyte nuclear maturation in mice [50] . Furthermore, epiregulin stimulates cumulus cell expansion in swine [51] . Epidermal growth factor-like peptides are under transcriptional regulation by gonadotropins in cumulus cells and have been associated with the activation of protein kinase A, MAPK, and ERK [52] . In our IVM system, epiregulin was ineffective at reversing the inhibitory effect of AICAR (data not shown). Thus, the action of AICAR in cumulus cells appears to be downstream of the stimulation by gonadotropins, EGF, and epiregulin. Despite a recent study showing that metformin activates MAPK, a key enzyme in a major EGF signaling pathway in human NCI-H292 airway epithelial cells [53] , it is difficult to propose such a mode of action for AMPK in AICAR-inhibited porcine cumulus cell expansion.
Therefore, we sought to decipher the role of AICAR in COC during IVM. Whereas the present study focused on the process of cumulus cell expansion, a recent report was aimed at identifying targets involved in the disruption of oocyte maturation by looking at the effect of metformin and AICAR [54] . They proposed that metformin and AICAR do not promote AMPK activation [54] . However, they indirectly looked at the activity of AMPK by measuring the phosphorylation of one among several AMPK targets, the acetyl-CoA carboxylase (ACC) [54] . Nevertheless, AMPK is known to be activated when phosphorylated on Thr172 at the alpha subunits [55, 56] . Thus, our approach was to determine whether AICAR could activate AMPK by measuring phosphorylation of the alpha subunits on Thr172. A significant 3-fold increase in AMPK phosphorylation was observed in response to AICAR (Fig. 2) , which clearly supports the activation of AMPK in porcine COC by AICAR. Activation of AMPK was also reported in bovine granulosa cells [57] , murine COC [35, 58] , bovine COC [48] , and other cell types [59] . The results of this study provide a clear demonstration that AICAR is effective in activating AMPK in porcine COC.
The AMPK enzyme senses the intracellular energy status and promotes rapid regulation by activating energy-producing pathways and downregulating energy-consuming metabolic processes. One example of this is the promotion of glucose transport in skeletal muscle [60] . In porcine COC, AICAR increased glucose uptake (Fig. 3A) , which provides support for the involvement of AMPK in the regulation of energetic metabolism. An intriguing feature of AMPK activation was that it led to an increase in glucose uptake while cumulus cell expansion was prevented. Thus, the AMPK activator appears to inhibit the ability of the cell to use glucose to produce hyaluronic acid. Recently reported to be critical in the acquisition of oocyte developmental competence [61] , the flow of the hexosamine biosynthetic pathway in cumulus cells involved the rate-limiting enzyme GFPT1 [16, 39] . Because the metabolic enzyme PFK2 (6-phosphofructo-2-kinase) involved in glycolysis has been reported to be phosphorylated by AMPK [40] , we postulated that GFPT1 could be a potential target of AMPK in its ability to produce substrate required to synthesize hyaluronic acid. To address this hypothesis, we supplemented AMPK ACTIVATION INHIBITS CUMULUS EXPANSION the culture medium with glucosamine. Because glucosamine is an alternative to glucose for glycosaminoglycan synthesis and enters the hexosamine biosynthetic pathway downstream from GFPT1 [16] , it could then bypass the inhibition of cumulus cell expansion observed in the presence of AICAR if this inhibition occurs upstream of GFPT1 (Fig. 4A) . This was not the case for either oocyte nuclear maturation or for cumulus cell expansion. These data support the fact that in the presence of AICAR, the substrates were not limiting for the synthesis of extracellular matrix in cumulus cells. Although it is not possible to draw a conclusion about the state of the GFPT1 enzymatic activity in the presence of AICAR, the synthesis of hyaluronic acid and other compounds of the extracellular matrix such as pentraxin3 and TFNAIP6 are potentially disrupted by the inhibition of protein synthesis. Activation of AMPK has been shown to inhibit protein synthesis in many different cell types [46, 47] . We have previously demonstrated that the amount of Cx43 protein present in cumulus cell is tightly regulated by gonadotropins during IVM and it is linked to gap junction communication dynamic regulation of permeability [8] . In the present study, AICAR decreased gap junction communication as measured by FRAP (Fig. 5A ). This result was further supported by Western blot analysis of Cx43 in COC where AICAR promoted a decrease in Cx43 (Fig. 5B) . The potential of cumulus cells to regulate their communication network through gap junctions was decreased by AMPK activation, limiting Cx43 synthesis. This decreased synthesis of Cx43 may explain the decrease in cumulus-cumulus gap junction communication as measured by FRAP (Fig. 5A) . The role of AMPK in Madin-Darby canine kidney cells has been described as crucial for the assembly and disassembly of tight junctions [62] , and a recent study stated that AMPK activation in Sertoli cells is necessary for blood-testis barrier junctional complex stability [63] . Furthermore, it is well known that AMPK may inhibit protein synthesis (see review [59] ). If protein synthesis regulation by AMPK activation in cumulus cells is broadly applicable, one might expect that the increase in PDE activity that is also subject to translational regulation [42] would be inhibited. The results from this study showed that AICAR inhibited the increase in PDE activity observed between 0 h and 20 h in culture. Even if there is a report showing that PDE activity was inhibited by AMPK activation [64] , the results of both Cx43 and PDE activity support the broad inhibition of translation by AICAR-activated AMPK.
To verify the latter, we compared the effect of AICAR to that of cycloheximide, a well-known protein synthesis inhibitor. As expected, cycloheximide inhibited cumulus cell expansion as already described [65] . This effect was in close agreement with that observed using AICAR and was also validated by protein content determination using the BCA protein assay kit.
When phosphorylated and activated, AMPK is known to downregulate mTOR signaling pathway [66, 67] . mTOR signaling is involved in the regulation of many cellular processes such as cell proliferation, growth, differentiation, migration and survival [68] [69] [70] . mTOR is a Ser/Thr protein kinase which is part of the TOR complex 1 composed of mTOR, Regulatory Associated Protein of mTOR (RAPTOR), PRAS40 (proline-rich AKT substrate 40 kDa), and mLST8 (mammalian lethal with sec-13). mTOR is also part of another complex TOR complex 2 which is composed of mTOR, mLST8, RICTOR (raptor independent companion of mTOR), mSIN1 (mammalian stress-activated protein kinase interacting protein 1), and PRO-TOR-1 (PRotein Observed with ricTOR-1) [71] [72] [73] [74] . TOR complex 1 is known to be involved in the stimulation of protein synthesis by phosphorylating proteins involved in translation like the ribosomal protein S6 kinases 1 and 2 (S6K1/2) and the eukaryotic initiation factor 4E binding proteins (4EBPs) [75] [76] [77] . It has also been reported that AICAR-activated AMPK directly phosphorylates TSC2 [44] and raptor [45] resulting in the inhibition of TOR complex 1 signaling. mTOR was recently reported to be localized in mouse cumulus cells [78] . The 2.5-fold increase of raptor phosphorylation in AICAR-activated AMPK (Fig. 7C) is supportive of TOR complex 1 decreased activity, suggesting protein synthesis inhibition. Further investigations would be required to assess whether the fundamental mechanism of AMPK activation might also include transcription factor sequestration, DNA packing, inhibition of RNA synthesis, or RNA degradation to name but a few.
In conclusion, this study demonstrates that AMPK activation inhibits both oocyte nuclear maturation and cumulus cell expansion in porcine COC. The degree of inhibition of cumulus cell expansion varies according to the AMPK activator, and the inhibitory effects of AICAR cannot be overridden by gonadotropins and/or EGF. During IVM, AMPK activation by AICAR increases glucose uptake by the COC and perturbs the active regulation of gap junction communication, connection 43 synthesis, and phosphodiesterase activity in cumulus cells. Protein content in COC is not increased in presence of AICAR, suggesting an inhibition of protein synthesis. The phosphorylation levels of specific kinases involved in the process of translation such as raptor are supportive of inhibition of TOR complex 1 signaling, resulting in protein synthesis inhibition. These results bring new considerations to the importance of this kinase in ovarian physiology and to the development of new oocyte culture medium.
